CAIHL read · Jun 8, 2026

← Back to Jun 8, 2026 scan

Have a Thorny Medical Question? Your Doctor May Be Using A.I. for That.

What CAIHL does

Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.

The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.

This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.

How this item reads through CAIHL

Primary user

clinician

Clinicians or care teams are the primary users. Patients are affected downstream.

Hosting

public

Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.

Interests

mixed

Multiple stakeholder interests in tension; the alignment is not stable.

Agency

constraining

Channels patients toward predetermined pathways or substitutes for patient capabilities.

One-sentence synthesis

Clinician-side AI use in the consultation without patient disclosure; constraining patient agency because the disclosure layer is missing.

How this item appeared in the daily scan

Editor's note: The AI is in the consultation; it is just not on the consent form. The patient is the only party to the encounter who cannot tell which sentence came from the clinician and which came from the model.

Summary: NYT: Doctors increasingly reach for AI tools — ChatGPT, ambient scribes, condition-specific copilots — for the harder questions inside the consultation, often without disclosing the AI's involvement to the patient.

Read the original source →

methodology

Limitations

CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.